View source for Navigating Nipah virus: Insights, challenges, and recommendations

'''Authors:''' Muhammad Hassan Hafeez, Hafsa Ajmal, Amna Nadeem, Shehroze Tabassum, Aymar Akilimali, *

'''Year:''' 2025

'''Journal:''' New Microbes and New Infections

=== Summary ===
This paper discusses the challenges posed by Nipah virus, a zoonotic pathogen, focusing on its diverse strains, recurrent outbreaks, diagnostic limitations, and the need for therapeutic advancements.

=== Key Findings ===
* Nipah virus (NiV) is a biosafety level 4 and category C pathogen belonging to the Paramyxoviridae family and Henipavirus genus
* NiV infections range from mild to severe, with an incubation period of 4–14 days and initial symptoms including fever, headache, and respiratory distress
* Notably, NiV-MY proves more virulent than NiV-BD, highlighting genotypic variations

=== Methodology ===
* '''Study Type:''' Mini-Narrative Review

=== Topics ===
Epidemiology, Virology

=== Relevance ===
The paper discusses the urgency for comprehensive biosecurity measures and early detection systems to address the evolving landscape of Nipah virus, emphasizing the need for collaborative efforts to mitigate its impact on public health.

=== Source ===
View the entire paper: [[File:main (2).pdf]]